scholarly journals A Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8, Bound to DNA Gyrase

Science ◽  
2009 ◽  
Vol 326 (5958) ◽  
pp. 1415-1418 ◽  
Author(s):  
M. J. Edwards ◽  
R. H. Flatman ◽  
L. A. Mitchenall ◽  
C. E.M. Stevenson ◽  
T. B.K. Le ◽  
...  
2014 ◽  
Vol 426 (10) ◽  
pp. 2023-2033 ◽  
Author(s):  
Stephen J. Hearnshaw ◽  
Marcus J. Edwards ◽  
Clare E. Stevenson ◽  
David M. Lawson ◽  
Anthony Maxwell

2014 ◽  
Vol 23 (8) ◽  
pp. 3632-3643 ◽  
Author(s):  
Lauren M. Gaskell ◽  
Thuy Nguyen ◽  
Keith C. Ellis
Keyword(s):  

2013 ◽  
Vol 23 (21) ◽  
pp. 5874-5877 ◽  
Author(s):  
Jenson Verghese ◽  
Thuy Nguyen ◽  
Lisa M. Oppegard ◽  
Lauren M. Seivert ◽  
Hiroshi Hiasa ◽  
...  

1996 ◽  
Vol 52 (a1) ◽  
pp. C160-C160
Author(s):  
F. T. F. Tsai ◽  
H. S. Subramanya ◽  
J. A. Brannigan ◽  
A. J. Wilkinson ◽  
T. Skarzynski ◽  
...  
Keyword(s):  

2015 ◽  
Vol 59 (11) ◽  
pp. 6689-6695 ◽  
Author(s):  
George A. Jacoby ◽  
Marian A. Corcoran ◽  
David C. Hooper

ABSTRACTQnr is a plasmid-encoded and chromosomally determined protein that protects DNA gyrase and topoisomerase IV from inhibition by quinolones. Despite its prevalence worldwide and existence prior to the discovery of quinolones, its native function is not known. Other synthetic compounds and natural products also target bacterial topoisomerases. A number were studied as molecular probes to gain insight into how Qnr acts. Qnr blocked inhibition by synthetic compounds with somewhat quinolone-like structure that target the GyrA subunit, such as the 2-pyridone ABT-719, the quinazoline-2,4-dione PD 0305970, and the spiropyrimidinetrione pyrazinyl-alkynyl-tetrahydroquinoline (PAT), indicating that Qnr is not strictly quinolone specific, but Qnr did not protect against GyrA-targeting simocyclinone D8 despite evidence that both simocyclinone D8 and Qnr affect DNA binding to gyrase. Qnr did not affect the activity of tricyclic pyrimidoindole or pyrazolopyridones, synthetic inhibitors of the GyrB subunit, or nonsynthetic GyrB inhibitors, such as coumermycin A1, novobiocin, gyramide A, or microcin B17.Thus, in this set of compounds the protective activity of Qnr was confined to those that, like quinolones, trap gyrase on DNA in cleaved complexes.


Nature ◽  
1991 ◽  
Vol 351 (6328) ◽  
pp. 624-629 ◽  
Author(s):  
Dale B. Wigley ◽  
Gideon J. Davies ◽  
Eleanor J. Dodson ◽  
Anthony Maxwell ◽  
Guy Dodson

2009 ◽  
Vol 54 (1) ◽  
pp. 213-220 ◽  
Author(s):  
C. Sissi ◽  
E. Vazquez ◽  
A. Chemello ◽  
L. A. Mitchenall ◽  
A. Maxwell ◽  
...  

ABSTRACT Simocyclinone D8, a coumarin derivative isolated from Streptomyces antibioticus Tü 6040, represents an interesting new antiproliferative agent. It was originally suggested that this drug recognizes the GyrA subunit and interferes with the gyrase catalytic cycle by preventing its binding to DNA. To further characterize the mode of action of this antibiotic, we investigated its binding to the reconstituted DNA gyrase (A2B2) as well as to its GyrA and GyrB subunits and the individual domains of these proteins, by performing protein melting and proteolytic digestion studies as well as inhibition assays. Two binding sites were identified, one (anticipated) in the N-terminal domain of GyrA (GyrA59) and the other (unexpected) at the C-terminal domain of GyrB (GyrB47). Stabilization of the A subunit appears to be considerably more effective than stabilization of the B subunit. Our data suggest that these two distinct sites could cooperate in the reconstituted enzyme.


Sign in / Sign up

Export Citation Format

Share Document